[Investigation of cephapirin in treatment of pulmonary infections (author's transl)].
D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001987:Bronchiectasis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage* / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008878:Middle Lobe Syndrome / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000201:enzymology; D013183:Sputum / Q000032:analysis; D013440:Sulfides / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000097:blood / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood
D000081:Acetamides; D002511:Cephalosporins; D011725:Pyridines; D013440:Sulfides; D000637:Transaminases